Resonance Health Limited (ASX:RHT)

Resonance Health Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	23	18	26	19	26	71
Market Cap Growth	-4.18%	-32.02%	36.13%	-25.00%	-63.87%	7.38%
Enterprise Value	24	18	21	13	18	63
Last Close Price	0.05	0.04	0.06	0.04	0.06	0.15
PE Ratio	29.50	-	155.74	-	-	122.01
PS Ratio	1.66	1.62	3.07	4.40	6.70	18.92
PB Ratio	2.09	1.91	2.41	1.95	2.42	6.04
P/TBV Ratio	5.61	7.47	7.18	1.95	2.42	6.04
P/FCF Ratio	488.26	22.26	22.77	-	-	63.34
P/OCF Ratio	54.46	14.36	19.01	-	-	60.96
EV/Sales Ratio	1.75	1.63	2.42	2.99	4.75	16.79
EV/EBITDA Ratio	17.51	-	-	-	-	151.50
EV/EBIT Ratio	25.90	-	-	-	-	158.72
EV/FCF Ratio	517.23	22.36	17.95	-	-	56.23
Debt / Equity Ratio	0.37	0.41	0.34	0.03	0.03	0.01
Debt / EBITDA Ratio	2.92	-	-	-	-	0.13
Debt / FCF Ratio	86.34	4.72	3.19	-	-	0.05
Net Debt / Equity Ratio	0.12	0.09	-0.29	-0.61	-0.61	-0.74
Net Debt / EBITDA Ratio	1.21	-0.59	7.71	4.61	4.37	-21.00
Net Debt / FCF Ratio	28.97	1.03	-2.73	13.68	4.14	-7.79
Asset Turnover	0.77	0.58	0.55	0.39	0.32	0.33
Quick Ratio	1.78	1.25	1.49	8.57	9.76	15.77
Current Ratio	1.87	1.28	1.51	8.63	10.34	15.84
Return on Equity (ROE)	7.33%	-17.05%	1.62%	-7.57%	-10.14%	5.39%
Return on Assets (ROA)	3.26%	-5.18%	-2.11%	-7.50%	-7.90%	2.18%
Return on Capital Employed (ROCE)	6.50%	-12.50%	-3.70%	-13.50%	-14.00%	3.40%
Earnings Yield	3.36%	-9.67%	0.64%	-4.03%	-4.42%	0.82%
FCF Yield	0.20%	4.49%	4.39%	-2.30%	-6.10%	1.58%
Buyback Yield / Dilution	-5.65%	2.81%	-1.59%	-	-1.97%	-4.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.